Prices are updated after-hours

Manufacturing 2022 - 05 - 18

KemPharm Inc

KMPH | $5.46 6.04% 0

|

(0.0% 1d) (0.7% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.7% 7d) (NaN% volume)
Earnings Calendar: 2023-03-30
Market Cap: $ 188,396,547
http://www.kempharm.com/
Sec Filling | Patents | 22 employees

(US) KemPharm is a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs to treat serious medical conditions through its proprietary LAT™ (Ligand Activated Therapy) technology. KemPharm utilizes its proprietary LAT™ technology to generate improved prodrug versions of FDA-approved drugs as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. KemPharm's prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, or ADHD, and stimulant use disorder. KemPharm's co-lead clinical development candidates for the treatment of ADHD, KP415 and KP484, are both based on a prodrug of d-methylphenidate, but have differing duration/effect profiles. In addition, KemPharm has received FDA approval for APADAZ®, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen.

urea treatment profitable

add to watch list Paper trade email alert is off

Edgewise Therapeutics Inc

EWTX | $15.64 3.71% 3.58% 560K

|

(0.0% 1d) (-2.2% 1m) (101.2% 1y) (0.0% 2d) (3.8% 3d) (2.8% 7d) (47.23% volume)
Earnings Calendar: 2023-11-02
Market Cap: $ 1,456,250,144
https://edgewisetx.com
Sec Filling | Patents | n/a employees

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Guided by its holistic drug discovery approach to targeting the muscle as an organ, Edgewise has combined its foundational expertise in muscle biology and small molecule engineering to build its proprietary, muscle focused drug discovery platform. Edgewise’s platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases.

drug discovery treatment

add to watch list Paper trade email alert is off

Hayward Holdings Inc

HAYW M | $13.7 2.01% 0.0% 1.3M

|

(0.0% 1d) (-8.7% 1m) (17.5% 1y) (0.0% 2d) (2.0% 3d) (3.7% 7d) (27.48% volume)
Earnings Calendar:
Market Cap: $ 2,941,614,529
https://investor.hayward.com
Sec Filling | Patents | 2095 employees

Hayward Holdings, Inc. is a global designer, manufacturer and marketer of a broad portfolio of pool equipment and associated automation systems. Headquartered in Berkeley Heights, NJ, Hayward designs, manufactures, and markets a full line of innovative, energy-efficient pool and spa equipment, with brands including AquaVac®, AquaRite®, ColorLogic®, Navigator®, OmniLogic®, OmniHub™, TriStar®, Super Pump®, TurboCell®, pHin™, CAT Controllers®, HCP Pumps and Saline C® Series.

brands energy

add to watch list Paper trade email alert is off

The Duckhorn Portfolio Inc

NAPA 4 | $8.4 0.48% 0.0% 720K

|

(0.0% 1d) (-7.7% 1m) (-43.4% 1y) (0.0% 2d) (0.5% 3d) (1.8% 7d) (-12.13% volume)
Earnings Calendar:
Market Cap: $ 969,436,499
https://www.duckhornportfolio.com
Sec Filling | Patents | n/a employees

The Duckhorn Portfolio is the premier producer of luxury wines in North America. The acclaimed Duckhorn Portfolio includes Duckhorn Vineyards, Decoy, Paraduxx, Goldeneye, Migration, Canvasback, Calera and Kosta Browne, each with its own dedicated winemaker.

add to watch list Paper trade email alert is off

Better Choice Company Inc

BTTR | $7.17 12.91% 0.14% 85K

|

(0.0% 1d) (-4.9% 1m) (1426.5% 1y) (0.0% 2d) (12.9% 3d) (14.7% 7d) (19.81% volume)
Earnings Calendar:
Market Cap: $ 6,407,119
https://www.betterchoicecompany.com
Sec Filling | Patents | 44 employees

Better Choice Company Inc. is a growing animal health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives. The company takes an alternative, nutrition-based approach to animal health relative to conventional dog and cat food offerings and position its portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. The company has a demonstrated, multi-decade track record of success selling trusted animal health and wellness products and leverage its established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. Better Choice sells the majority of its dog food, cat food and treats under the Halo and TruDog brands, which are focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats.

animals brands pets

add to watch list Paper trade email alert is off

GH Research PLC

GHRS | $11.37 -2.99% -3.08% 42K

|

(0.0% 1d) (7.1% 1m) (43.0% 1y) (0.0% 2d) (-3.6% 3d) (2.4% 7d) (-37.57% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 591,560,009
https://www.ghres.com
Sec Filling | Patents | 2021 employees

(IE) GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression.

treatment

add to watch list Paper trade email alert is off

Regencell Bioscience Holdings Ltd

RGC | $5.81 -9.78% -10.84% 27K

|

(0.0% 1d) (54.1% 1m) (-78.7% 1y) (0.0% 2d) (-11.5% 3d) (2.7% 7d) (773.69% volume)
Earnings Calendar:
Market Cap: $ 75,604,751
https://www.regencellbioscience.com
Sec Filling | Patents | 2021 employees

Regencell Bioscience Holdings Limited is an early-stage bioscience company that focuses on research, development and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. The Company started in Hong Kong in 2014 and completed its first research study using personalized TCM formula in Hong Kong. The Company aims to launch three liquid-based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients in Hong Kong first and subsequently to other markets.

treatment

add to watch list Paper trade email alert is off

OZOP ENERGY SOLUTIONS, INC.

OZSC | $0.0008 120.0% 36M

|

(0.0% 1d) (-10.0% 1m) (-83.9% 1y) (0.0% 2d) (0.0% 3d) (5.9% 7d) (3.33% volume)
Earnings Calendar:
Market Cap: $ 4,799,669

Sec Filling | Patents | 15 employees

power conversion technologies, inc. designs and manufactures power electronic equipment for the use in power conversion. the company was incorporated in 1991 and is based in zelienople, pennsylvania.

add to watch list Paper trade email alert is off

Mitesco, Inc.

MITI | $0.439 -9.99% 5K

|

(0.0% 1d) (69.2% 1m) (-59.6% 1y) (0.0% 2d) (0.0% 3d) (7.3% 7d) (-14.74% volume)
Earnings Calendar:
Market Cap: $ 2,473,784
https://truenaturepharma.com/
Sec Filling | Patents | 6 employees

(US) true nature is a development stage company focused on consolidating businesses in the compound pharmacy industry that serve both the human and veterinary markets. starting in the southeast, the company intends to acquire compounders across the us that meet their criteria and present a complementary fit to the true nature platform. mission: to unlock the potential of the compounding pharmacy industry to improve human and animal health, serve unmet patient needs, elevate the dignity of skilled pharmacists, and build shareholder value through the delivery of quality, cost effective, and innovative healthcare products and pharmaceuticals to the world. vision: to become globally recognized for our best practices focused on driving quality, efficiency and sustainability in the compounding pharmaceutical industry, natural solutions for healthy living, and novel approaches for delivery of these solutions.

add to watch list Paper trade email alert is off

Icecure Medical Ltd

ICCM | $1.22 0.82% 66K

|

(0.0% 1d) (2.1% 1m) (-8.3% 1y) (0.0% 2d) (0.0% 3d) (0.8% 7d) (-33.51% volume)
Earnings Calendar: 2023-08-14
Market Cap: $ 55,660,589
https://icecure-medical.com
Sec Filling | Patents | n/a employees

Founded in 2006, Israel-based IceCure Medical develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally-invasive technology is a safe and effective alternative to hospital surgical tumor removal that is easily performed in a relatively short procedure. The system is marketed and sold worldwide, after receiving FDA and CE approvals.

treatment cancer urea israel kidney lung cancer lungs

add to watch list Paper trade email alert is off

Humacyte Inc

HUMA | $3.925 6.08% 5.73% 2.1M

|

(0.0% 1d) (25.2% 1m) (15.9% 1y) (0.0% 2d) (6.2% 3d) (9.5% 7d) (-17.74% volume)
Earnings Calendar: 2024-03-22
Market Cap: $ 467,403,632
https://humacyte.com
Sec Filling | Patents | n/a employees

Humacyte, Inc., is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte’s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Pre-clinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte’s HAVs were the first product to receive the FDA’s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation and received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.

diabetic diabetes ceiling treatment defense t-cell

add to watch list Paper trade email alert is off

ALTEROLA BIOTECH INC.

ABTI | $0.0054 1946.88% 40K

|

(0.0% 1d) (68.8% 1m) (-84.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-45.97% volume)
Earnings Calendar:
Market Cap: $ 7,466,380

Sec Filling | Patents | 1 employees

alterola biotech inc. (otc: “abti”) is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary product platform across a broad range of therapeutic areas. the company has a number of proprietary drug pipeline candidates including cannabinoids, cannabinoid-like molecules and non-cannabinoid molecules, which are under development for a range of indications. abti is also focussed on producing quality, low cost of goods ingredients for the pharmaceutical, food and cosmetic sectors, from synthetic, biosynthetic and botanical sources. it is also focussed on improving the drug delivery of such classes of compounds and has a range of proprietary technologies in development to enhance the delivery and bioavailability of its product portfolio. geographically the company has a presence in the uk, ireland, netherlands (europe), usa, australia, and china.

add to watch list Paper trade email alert is off

Cell MedX Corp.

CMXC | $0.037 -63.33% 39K

|

(0.0% 1d) (66.7% 1m) (39900.0% 1y) (0.0% 2d) (0.0% 3d) (-20.0% 7d) (355.32% volume)
Earnings Calendar:
Market Cap: $ 10,997,746
http://cellmedx.com/
Sec Filling | Patents | 33625 employees

(US) espa.ca is operated by avyonce cosmedics inc. our espa.ca website features a range of spa equipment, spa furniture and spa products. at avyonce cosmedics inc. we can help develop your spa from start up or work with you to upgrade your existing business. espa.ca offers the brands you can trust. combining performance, pleasure, safety and creativity, the team provides the highest quality equipment and products to ensure your clients will have an unforgettable spa experience.

add to watch list Paper trade email alert is off

Cannabis Sativa, Inc.

CBDS 4 | $0.019 -28.22% 27K

|

(0.0% 1d) (22.7% 1m) (-62.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (278.38% volume)
Earnings Calendar:
Market Cap: $ 1,687,467
https://cannabissativainc.com/
Sec Filling | Patents | 6 employees

(US) cannabis sativa inc trades on the otcqb as $cbds cannabis sativa, inc., through its subsidiaries wild earth naturals, white rabbit, hi brands international, presto doctor, and ibudtender, develops, manufactures, and sells herbal based skin care products in the united states and internationally. it offers herbal based line of products, including go deep, a deep penetrating healing salve that reduces pain and inflammation when massaged into muscles, ligaments, tendons, and joints; go deep extra, a deep penetrating pain relief ointment for use in mitigating migraine and sinus headaches; face garden, an antioxidant and moisturizing cream for the face; body garden, a moisturizing body lotion; and lip garden, an emollient balm. the company also engages in the research, development, and licensing of natural cannabis products comprising cannabis formulations, edibles, topicals, strains, recipes, and delivery systems. it markets and sells its products through sales professionals, as well as thr

education

add to watch list Paper trade email alert is off

SONIC FOUNDRY INC

SOFO | $0.0003 1701.19% 27K

|

(0.0% 1d) (107.1% 1m) (-96.6% 1y) (0.0% 2d) (0.0% 3d) (-3.3% 7d) (-43.6% volume)
Earnings Calendar: 2022-12-08
Market Cap: $ 3,642

Sec Filling | Patents | 177 employees

sonic foundry (nasdaq: sofo) is the trusted global leader for video capture, management and webcasting solutions in education, business and government. the patented mediasite enterprise video platform transforms communications, training, education and events for more than 3,800 customers in 65 countries. sonic foundry is a leader in aragon research’s globe for video content management, frost & sullivan’s lecture capture leader for seven consecutive years, a leader in forrester’s enterprise video platforms and webcasting wave and a challenger in gartner’s magic quadrant for enterprise video content management.

communication hepatitis education

add to watch list Paper trade email alert is off

Leet Technology Inc.

LTES | $0.05 9900.0% 3.1K

|

(0.0% 1d) (2566.7% 1m) (-42.0% 1y) (0.0% 2d) (-20.0% 3d) (-20.0% 7d) (-41.94% volume)
Earnings Calendar:
Market Cap: $ 7,554,813
https://www.blowanddrive.com/
Sec Filling | Patents | 17 employees

(US) based in malaysia, leet inc. is a publicly traded technology company (otc: ltes) that provides a platform for competitive gaming (including e-sports and arcade games ) in the fast growing southeast asian market. leet is driven by the strength of our connection with esports communities at the grassroots level, and a differentiated business model. we have established strategic revenue-generating partnerships with leading ict and ott companies across key markets in the asia pacific region. leet has since embarked on several successful strategic partnerships with leading brands across the region: digi (malaysia), cellcard (cambodia), smart-pdlt (philippines), and paytm (india).

add to watch list Paper trade email alert is off

Sylvamo Corp

SLVM 4 | $62.14 2.47% 0.0% 250K

|

(0.0% 1d) (2.7% 1m) (37.0% 1y) (0.0% 2d) (2.5% 3d) (6.3% 7d) (-22.62% volume)
Earnings Calendar:
Market Cap: $ 2,576,427,366
https://www.sylvamo.com
Sec Filling | Patents | 2021 employees

Sylvamo is the world’s paper company with mills in Europe, Latin America and North America. Our vision is to be the employer, supplier and investment of choice. We transform renewable resources into papers that people depend on for education, communication and entertainment. Headquartered in Memphis, Tennessee, we employ more than 7,000 colleagues. Net sales for the last 12 months ending June 30, 2021, were $3.2 billion.

communication renewable education

add to watch list Paper trade email alert is off

Procaps Group, S.A.

PROC | $2.9 -5.08% 1.8K

|

(0.0% 1d) (-8.3% 1m) (-40.4% 1y) (0.0% 2d) (0.0% 3d) (5.8% 7d) (19733.33% volume)
Earnings Calendar: 2023-05-15
Market Cap: $ 327,190,131
https://www.procapsgroup.com
Sec Filling | Patents | 2021 employees

Procaps is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in Latin America and, as of December 31, 2020, had more than 4,700 collaborators working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potency clinical solutions.

add to watch list Paper trade email alert is off

Sonendo Inc

SONX 4 | $0.0947 3.6% 430K

|

(0.0% 1d) (-14.3% 1m) (-94.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-45.9% volume)
Earnings Calendar:
Market Cap: $ 6,671,603
https://sonendo.com
Sec Filling | Patents | 2021 employees

Sonendo is a company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo has developed the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The GentleWave System, the first and only FDA-cleared system for root canal therapy, or RCT, that employs a sterilized, single-use Procedure Instrument, to transform RCT by addressing the limitations of conventional methods. The system utilizes its proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure.

energy optical

add to watch list Paper trade email alert is off

Velo3D Inc - New

VLD M | $0.2445 -0.61% 0.0% 2.9M

|

(0.0% 1d) (-56.6% 1m) (-88.1% 1y) (0.0% 2d) (-4.0% 3d) (-4.0% 7d) (-40.7% volume)
Earnings Calendar: 2024-03-26
Market Cap: $ 72,407,470
https://www.velo3d.com
Sec Filling | Patents | 2 employees

Velo3D is a metal 3D printing technology company. 3D printing—also known as additive manufacturing (AM)—has a unique ability to improve the way high-value metal parts are built. However, legacy metal AM has been greatly limited in its capabilities since its invention almost 30 years ago. This has prevented the technology from being used to create the most valuable and impactful parts, restricting its use to specific niches where the limitations were acceptable. Velo3D has overcome these limitations so engineers can design and print the parts they want. The company’s solution unlocks a wide breadth of design freedom and enables customers in space exploration, aviation, power generation, energy and semiconductor to innovate the future in their respective industries. Using Velo3D, these customers can now build mission-critical metal parts that were previously impossible to manufacture. The end-to-end solution includes the Flow™ print preparation software, the Sapphire® family of printers, and the Assure™ quality control system—all of which are powered by Velo3D’s Intelligent Fusion™ manufacturing process. The company delivered its first Sapphire® system in 2018 and has been a strategic partner to innovators such as SpaceX, Honeywell, Honda, Chromalloy, and Lam Research. Velo3D has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021.

energy semiconductor

add to watch list Paper trade email alert is off

← Previous
1
2
Next →

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

78%

22%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 28M

|

AGBA | $2.94 135.2% 57.48% 66M

|

EDBL | News | $6.46 71.81% 41.8% 2M

|

MTC | $2.25 44.23% 30.67% 6M

|

Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M

|

SHIM | $3.05 35.56% 26.23% 1.1M

|

HKIT | $1.345 31.86% 24.16% 390K

|

Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M

|

Wholesale Trade

OST | $0.512 28.0% 21.88% 290K

|

POET | $1.59 27.2% 21.38% 4.2M

|

Last 48 Hours Insiders Buying

MEGI | $11.975 1.87% 0.04% 140K

|

| 00:30
CTRN P 29000 | $22.25 0.14% 0.13% 100K

|

| 22:00
CONN | $3.71 1.37% 1.35% 72K

|

| 21:30
TGEN P 6000 | $0.6897 39.71% 2.3K

|

| 18:30
CMTV P 700 | $15.74 17.43% 12K

|

Finance and Insurance

| 18:30
FNB | $13.63 2.17% 0.0% 2.5M

|

| 17:30
RMCF | $3.57 0.28% 2.8K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar